improving Oncology study with built-in KRAS Assay products and services and RAS Assays
during the rapidly evolving area of oncology investigate, correct and effective mutation screening is essential for establishing qualified therapies. The KRAS solutions System performs a pivotal part Within this landscape by featuring detailed alternatives for KRAS mutation profiling and Investigation. KRAS mutations, found in roughly 95% of RAS-co